In the last trading session, 1.13 million Staar Surgical Co (NASDAQ:STAA) shares changed hands as the company’s beta touched 0.75. With the company’s per share price at $17.05 changed hands at -$0.36 or -2.07% during last session, the market valuation stood at $841.00M. STAA’s last price was a discount, traded about -208.97% off its 52-week high of $52.68. The share price had its 52-week low at $13.50, which suggests the last value was 20.82% up since then. When we look at Staar Surgical Co’s average trading volume, we note the 10-day average is 1.14 million shares, with the 3-month average coming to 1.01 million.
Analysts gave the Staar Surgical Co (STAA) stock a consensus recommendation rating of Buy, calculated at a mean rating of 2.69. If we narrow down to specifics, the data shows that 1 out of 13 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 1 recommended STAA as a Hold, 11 felt it is a Buy and 0 rated the stock as Underweight. Staar Surgical Co’s EPS for the current quarter is expected to be -0.58.
Staar Surgical Co (NASDAQ:STAA) trade information
Instantly STAA was in red as seen at the end of in last trading. With action -7.03%, the performance over the past five days has been red. The company’s shares are showing year-to-date downside of -29.81%, with the 5-day performance at -7.03% in the red. However, in the 30-day time frame, Staar Surgical Co (NASDAQ:STAA) is 3.46% up. Looking at the short shares, we see there were 4.57 million shares sold at short interest cover period of 3.35 days.
The consensus price target for the stock as assigned by Wall Street analysts is 48, meaning bulls need an upside of 64.48% from its current market value. According to analyst projections, STAA’s forecast low is 45.03 with 85 as the target high. To hit the forecast high, the stock’s price needs a -398.53% plunge from its current level, while the stock would need to soar -164.11% for it to hit the projected low.
Staar Surgical Co (STAA) estimates and forecasts
Year-over-year growth is forecast to reach -16.93% down from the last financial year.
Consensus estimates given by 11 financial analysts project the company’s revenue in the current quarter to hit an average of 40.33M. 11 analysts are of the opinion that Staar Surgical Co’s revenue for the current quarter will be 41.1M. The company’s revenue for the corresponding quarters a year ago was 77.36M and 99M respectively. According to analysts, the company will likely register a growth in its current quarter sales, forecast at -47.87%. The estimates for the next quarter sales put growth at -58.49%.
The 2025 estimates are for Staar Surgical Co earnings to decrease by -530.67%, but the outlook for the next 5-year period is at 20.23% per year.
STAA Dividends
Staar Surgical Co is expected to release its next quarterly earnings report on 2025-Feb-10.
Staar Surgical Co (NASDAQ:STAA)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 0.51% of Staar Surgical Co shares while 102.12% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 102.64%. There are 102.12% institutions holding the Staar Surgical Co stock share, with BROADWOOD CAPITAL INC the top institutional holder. As of 2024-06-30, the company held 21.9196% of the shares, roughly 10.77 million STAA shares worth $512.68 million.
BLACKROCK INC. holds the second largest percentage of outstanding shares, with 15.3123% or 7.49 million shares worth $356.54 million as of 2024-06-30.
Among Mutual Funds, the top two as of Jan 31, 2025 were iShares Core S&P Smallcap ETF and Vanguard Total Stock Market Index Fund . With 3.17 shares estimated at $54.01 million under it, the former controlled 6.42% of total outstanding shares. On the other hand, Vanguard Total Stock Market Index Fund held about 3.14% of the shares, roughly 1.55 shares worth around $26.4 million.
